ArticleMedComm2025
Targeting EZH1/2: tackling epigenetic resistance advances cancer therapy.
Ram Abou Zaki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleMedComm2025
Ram Abou Zaki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.